In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:
Pharmacologically active Substance | Marker residue | Animal Species | MRL | Target Tissues | Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) | Therapeutic Classification
‘Cabergoline | Cabergoline | Bovine | 0,10 μg/kg | Fat | NO ENTRY | Prolactin inhibitor’
0,25 μg/kg | Liver
0,50 μg/kg | Kidney
0,15 μg/kg | Muscle
0,10 μg/kg | Milk